期刊文献+

The influence of metabolic syndrome on atrial fibrillation recurrence: five-year outcomes after a single cryoballoon ablation procedure 被引量:5

下载PDF
导出
摘要 BACKGROUND Metabolic syndrome(MetS)has been reported as a risk factor of atrial fibrillation(AF)recurrence after radi-ofrequency catheter ablation.This study aimed to investigate the long-term influence of MetS on paroxysmal AF recurrence after a single cryoballoon ablation procedure,which was scarcely investigated yet in Chinese population.METHODS In total,137 paroxysmal AF patients who had successfully completed a single cryoballoon ablation procedure at Fuwai Hospital,Beijing,China from December 2013 to October 2015 were enrolled.Excepting for patients with AF recurrence,all patients were followed up for no less than five years.Independent predictors of AF recurrence were determined by Cox propor-tional hazards regression analysis.RESULTS Among 137 paroxysmal AF patients,91 patients(66.4%)had successfully achieved overall five-year follow-up after a single cryoballoon ablation procedure,and 44 patients(32.1%)had MetS.Patients with MetS had a significant lower incidence of freedom from AF recurrence than those without MetS(50.0%vs.74.2%,log-rank P<0.01)during the five-year follow-up.MetS(HR=1.95,95%CI:1.069−3.551,P=0.030)was an independent predictor of AF recurrence after adjusting for multiple factors.After the second year post cryoballoon ablation procedure,the recurrence rate of AF gradually increased in patients with MetS,in con-trast,decreased recurrence rate of AF in patients without MetS.CONCLUSIONS MetS is an independent predictor for five-year AF recurrence after a single cryoballoon ablation procedure in paroxysmal AF patients.Combination therapy of AF and MetS may improve the long-term outcomes of AF patients.
出处 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2021年第12期1019-1028,共10页 老年心脏病学杂志(英文版)
  • 相关文献

参考文献1

二级参考文献9

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3041
  • 2Isomaa B,Almgren P,Tuomi T,et al.Cardiovascular morbidity and mortality associated with the metabolic syndrome.Diabetes Care,2001,24:683-689.
  • 3Ridker PM,Burning JE,Cook NR,et al.C-reactive Protein,the metabolic syndrome,and risk of incident cardiovascular events.An 8-year follow-up of 14719 initially healthy American women.Circulation,2003,107:391-397.
  • 4Baltali M,Gokcel A,Kiziltan HT,et al.Association between the metabolic syndrome and newly diagnosed coronary artery disease.Diabetes Nutr Metab,2003,16:169-175.
  • 5International Diabetes Federation.The IDF consensus worldwide definition of the metabolic syndrome.Berlin,2005.14.
  • 6World Health Organization.Definition,diagnosis and classification of diabetes mellitus and its complication.WHO/NCD/NCS,1999.31-32.
  • 7Expert Panel on Detection,Evaluation,and treatment of high blood cholesterol in adults.executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection,evaluation,and treatment of high blood cholesterol in adults (adult treatment panel Ⅲ).JAMA,2001,285:2486-2497.
  • 8Alexander CM,Landsman PB,teutsch SM,et al.NCEP-defined metabolic syndrome,diabetes,and prevalence of coronary heart disease among NHANES Ⅲ participants age 50 years and older.Diabetes,2003,52:1210-1214.
  • 9The European Group for the study of Insulin Resistance (EGIR).frequency of the WHO metabolic syndrome in european cohorts,and an alternative definition of an insulin resistance syndrome..Diabetes Metab,2002,2:354-376.

共引文献77

同被引文献48

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部